KATHLEEN VENESKY: Open Payments
NPI 1811226806 · GLEN MILLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 119 payments from 17 companies in 2025. Trend: 2023 $905 · 2024 $1,645 · 2025 $1,990
Food & beverage: $1,990
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $622 |
| Janssen Biotech, Inc. | 31 | $373 |
| Amgen Inc. | 12 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $148 |
| GENZYME CORPORATION | 3 | $95 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Galderma Laboratories, L.P. | 4 | $80 |
| Organon LLC | 5 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $61 |
| LEO Pharma Inc. | 3 | $61 |
Products named: SKYRIZI, TREMFYA, OTEZLA, RINVOQ, ILUMYA, BOTOX, DUPIXENT, Sotyktu.
Industry payments across PA — which companies pay providers there.
